These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8168931)

  • 1. Free hydroxyl groups are not required for endotoxic activity of lipid A.
    Tanamoto K
    Infect Immun; 1994 May; 62(5):1705-9. PubMed ID: 8168931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of endotoxic activities in a chemically synthesized lipid A precursor after acetylation.
    Tanamoto K
    Infect Immun; 1995 Feb; 63(2):690-2. PubMed ID: 7822041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant role of the substituents on the hydroxyl groups of 3-hydroxy fatty acids of non-reducing glucosamine in lipid A for the endotoxic and antagonistic activity.
    Tanamoto K
    FEBS Lett; 1994 Sep; 351(3):325-9. PubMed ID: 8082789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxic properties of free lipid A from Porphyromonas gingivalis.
    Tanamoto KI; Azumi S; Haishima Y; Kumada H; Umemoto T
    Microbiology (Reading); 1997 Jan; 143 ( Pt 1)():63-71. PubMed ID: 9025279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities.
    Galanos C; Lüderitz O; Rietschel ET; Westphal O; Brade H; Brade L; Freudenberg M; Schade U; Imoto M; Yoshimura H
    Eur J Biochem; 1985 Apr; 148(1):1-5. PubMed ID: 2579812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate.
    Kotani S; Takada H; Takahashi I; Tsujimoto M; Ogawa T; Ikeda T; Harada K; Okamura H; Tamura T; Tanaka S
    Infect Immun; 1986 Jun; 52(3):872-84. PubMed ID: 3011676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxic properties of lipid A from Comamonas testosteroni.
    Tanamoto KI; Iida T; Haishima Y; Azumi S
    Microbiology (Reading); 2001 May; 147(Pt 5):1087-1094. PubMed ID: 11320112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate.
    Tanamoto K; Zähringer U; McKenzie GR; Galanos C; Rietschel ET; Lüderitz O; Kusumoto S; Shiba T
    Infect Immun; 1984 May; 44(2):421-6. PubMed ID: 6715042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Takahashi I; Ikeda T; Otsuka K; Shimauchi H; Kasai N; Mashimo J
    Infect Immun; 1985 Jul; 49(1):225-37. PubMed ID: 3891627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipid A moiety of Porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice.
    Tanamoto K; Azumi S; Haishima Y; Kumada H; Umemoto T
    J Immunol; 1997 May; 158(9):4430-6. PubMed ID: 9127008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinylated lipid A is a potent and specific inhibitor of endotoxin mitogenicity.
    Tanamoto K; Ishibashi N
    J Gen Microbiol; 1992 Dec; 138(12):2503-8. PubMed ID: 1487722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs.
    Kusumoto S; Fukase K; Fukase Y; Kataoka M; Yoshizaki H; Sato K; Oikawa M; Suda Y
    J Endotoxin Res; 2003; 9(6):361-6. PubMed ID: 14733722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically detoxified lipid A precursor derivatives antagonize the TNF-alpha-inducing action of LPS in both murine macrophages and a human macrophage cell line.
    Tanamoto K
    J Immunol; 1995 Dec; 155(11):5391-6. PubMed ID: 7594555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiological activities of a chemically synthesized lipid A of Porphyromonas gingivalis.
    Ogawa T; Asai Y; Yamamoto H; Taiji Y; Jinno T; Kodama T; Niwata S; Shimauchi H; Ochiai K
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):273-81. PubMed ID: 10891650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxic properties of synthetic pentaacyl lipid A precursor Ib and a structural isomer.
    Rietschel ET; Brade L; Schade U; Galanos C; Freudenberg M; Lüderitz O; Kusumoto S; Shiba T
    Eur J Biochem; 1987 Nov; 169(1):27-31. PubMed ID: 3315662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiological activities of synthetic lipid A analogs with low endotoxicity.
    Kotani S; Takada H; Takahashi I; Ogawa T; Tsujimoto M; Shimauchi H; Ikeda T; Okamura H; Tamura T; Harada K
    Infect Immun; 1986 Dec; 54(3):673-82. PubMed ID: 3781622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid A's with different fatty acid compositions.
    Kanegasaki S; Tanamoto K; Yasuda T; Homma JY; Matsuura M; Nakatsuka M; Kumazawa Y; Yamamoto A; Shiba T; Kusumoto S
    J Biochem; 1986 Apr; 99(4):1203-10. PubMed ID: 2423510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of lipid A and its analogues for investigation of the structural basis for their bioactivity.
    Fujimoto Y; Adachi Y; Akamatsu M; Fukase Y; Kataoka M; Suda Y; Fukase K; Kusumoto S
    J Endotoxin Res; 2005; 11(6):341-7. PubMed ID: 16303089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxic and immunobiological activities of a chemically synthesized lipid A of Helicobacter pylori strain 206-1.
    Ogawa T; Asai Y; Sakai Y; Oikawa M; Fukase K; Suda Y; Kusumoto S; Tamura T
    FEMS Immunol Med Microbiol; 2003 May; 36(1-2):1-7. PubMed ID: 12727359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities.
    Kanegasaki S; Kojima Y; Matsuura M; Homma JY; Yamamoto A; Kumazawa Y; Tanamoto K; Yasuda T; Tsumita T; Imoto M
    Eur J Biochem; 1984 Sep; 143(2):237-42. PubMed ID: 6468393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.